Smith & Nephew plc (SNNUF)
OTCMKTS
· Delayed Price · Currency is USD
14.88
0.00 (0.00%)
Mar 7, 2025, 3:00 PM EST
Smith & Nephew Revenue
In the year 2024, Smith & Nephew had annual revenue of $5.81B with 4.70% growth. Smith & Nephew had revenue of $2.98B in the half year ending December 31, 2024, with 14.07% growth.
Revenue
5.81B
Revenue Growth
+4.70%
P/S Ratio
n/a
Revenue / Employee
341.76K
Employees
17,000
Market Cap
12.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.81B | 261.00M | 4.70% |
| Dec 31, 2023 | 5.55B | 334.00M | 6.40% |
| Dec 31, 2022 | 5.22B | 3.00M | 0.06% |
| Dec 31, 2021 | 5.21B | 652.00M | 14.30% |
| Dec 31, 2020 | 4.56B | -578.00M | -11.25% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.79B |
| SS Innovations International | 16.04M |
| Veradigm | 1.53B |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| Silence Therapeutics | 43.26M |
| BioStem Technologies | 210.49M |
Smith & Nephew News
- 7 days ago - Smith & Nephew gains after report it may evaluate a break-up - Seeking Alpha
- 9 days ago - Wound Care Market Size is Expected to Reach USD 32.75 Billion by 2033, Growing at a CAGR of 3.94%: Straits Research - GlobeNewsWire
- 14 days ago - MARKET REPORT: Recovery hopes breathe life into hip replacement maker Smith & Nephew - This is Money
- 15 days ago - Smith & Nephew plc (SNN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Smith & Nephew plc 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 15 days ago - Smith & Nephew Non-GAAP EPS of $0.843, revenue of $5.81B - Seeking Alpha
- 15 days ago - We are having constructive engagement with activist shareholders, says Smith & Nephew CEO - CNBC
- 15 days ago - Hip replacement firm Smith & Nephew’s profit surges amid recovery in US sales - Evening Standard